These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7040918)

  • 1. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei].
    Borisov VA; Frolov AF
    Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune processes induced by dysentery bacilli in mice.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):595-601. PubMed ID: 373684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG response of dysenteric patients to antigens coded by the virulence plasmid of enteroinvasive pathogens.
    Pál T; Brasch G
    Acta Microbiol Hung; 1987; 34(2):159-63. PubMed ID: 3326389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of immunofluorescence method in the diagnosis and study of pathogenesis of acute dysentery].
    Pogorel'skaia LV; Vul'fovich IuV; Plotnikova IuK
    Sov Med; 1991; (6):84-6. PubMed ID: 1887317
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of serum and fecal antibody responses of patients with naturally acquired Shigella sonnei infection.
    Winsor DK; Mathewson JJ; DuPont HL
    J Infect Dis; 1988 Nov; 158(5):1108-12. PubMed ID: 3053924
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of antibody screening in selection of subjects for field trials of Shigella vaccines.
    Cohen D; Green MS; Block C; Rouach T; Ofek I; Swartz T; Lowell G; Tramont E
    Ann Sclavo Collana Monogr; 1986; 3(1-2):151-4. PubMed ID: 3322338
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of the synergistic action of enterotoxin on the specific protective complex of Shigella sonnei].
    Korneeva SA; Kovalevskaia IL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):38-41. PubMed ID: 1789032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the mechanism of formation of protracted forms of dysentery].
    Suptel' EA; Moshchich PS; Borisov VA; Zagornaia NB; Pavlovich SI
    Vrach Delo; 1978 Dec; (12):115-8. PubMed ID: 369138
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
    Cohen D; Green MS; Block C; Rouach T; Ofek I
    J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune processes in the course of infection with dysentery bacilli. III. Protective activity of spleen cells and serum from mice immunized with killed dysentery bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1977; 25(1):69-78. PubMed ID: 327970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibody levels in patients with bacillary dysentery and carriers. III. IgG, IgM and IgA antibody responses in sonnei dysentery].
    Miyata Y; Kitaura T; Sugiyama S
    Kansenshogaku Zasshi; 1976 Jul; 50(7):247-56. PubMed ID: 828664
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of Shigella sonnei strains opposite in their virulence on different links in the immune system].
    Nikolaeva TN; Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):22-6. PubMed ID: 1279912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Manifestations of genotypic and phenotypic heterogeneity in populations of Shigella sonnei and of humans at different phases of the development of the epidemic process].
    Shapiro MI; Nechaeva NE; Degtiarev AA; Toluzakova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Nov; (11):42-6. PubMed ID: 3541470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of serum antibodies of patients, carriers and healthy persons during a dysentery outbreak.
    Anzai H; Okamoto M; Tone K; Yoshifuku K; Mokuhara M
    Kitasato Arch Exp Med; 1972 Mar; 45(1):1-16. PubMed ID: 4570385
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
    Van de Verg L; Herrington DA; Murphy JR; Wasserman SS; Formal SB; Levine MM
    Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the physicochemical nature of specific antibodies in the different forms and course of dysentery in children].
    Nesterina LF; Vasil'eva IG
    Vopr Okhr Materin Det; 1973 Dec; 18(12):16-20. PubMed ID: 4594382
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune processes in the course of infection with dysentery bacilli. I. Transfer of immunity by means of spleen cells.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(3):315-26. PubMed ID: 786209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological characteristics of 2 Shigella sonnei biotypes].
    Toluzakova NV
    Tr Inst Im Pastera; 1978; 50():26-33. PubMed ID: 394393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Shigella toxicity in immunological tolerance].
    Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):95-9. PubMed ID: 2448979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.